4.8 Article

Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis

期刊

ONCOGENE
卷 30, 期 8, 页码 896-906

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.470

关键词

BRMS1; melanoma; tumor progression; prognosis; angiogenesis

资金

  1. Canadian Institutes of Health Research [MOP-84559, MOP-93810]
  2. Canadian Dermatology Foundation
  3. Natural Sciences and Engineering Research Council of Canada
  4. University of British Columbia
  5. CIHR Skin Research Training Centre

向作者/读者索取更多资源

Breast cancer metastasis suppressor 1 (BRMS1) has been reported to suppress metastasis without significantly affecting tumorigenicity in breast cancer and ovarian cancer. To investigate the role of BRMS1 in human melanoma progression and prognosis, we established tissue microarray and BRMS1 expression was evaluated by immunohistochemistry in 41 dysplastic nevi, 90 primary melanomas and 47 melanoma metastases. We found that BRMS1 expression was significantly decreased in metastatic melanoma compared with primary melanoma or dysplastic nevi (P = 0.021 and 0.001, respectively, chi(2) test). In addition, reduced BRMS1 staining was significantly correlated with American Joint Committee on Cancer stages (P = 0.011, chi(2) test), but not associated with tumor thickness, tumor ulceration and other clinicopathological parameters. Furthermore, BRMS1 expression was significantly correlated with disease-specific 5-year survival of melanoma patients (P = 0.007, log-rank test). Multivariate Cox regression analysis revealed that BRMS1 staining was an independent prognostic factor for melanoma patients (relative risk 0.51; confidence interval = 0.29-0.91; P = 0.022). Moreover, we demonstrated that BRMS1 overexpression inhibited endothelial cell growth and tube formation ability by suppressing NF-kappa B activity and IL-6 expression in vitro. We also showed that knockdown of BRMS1 increased IL-6 expression and promoted endothelial cell growth and tube formation. In addition, our data revealed that the BRMS1-mediated IL-6 expression is dependent on NF-kappa B. Strikingly, our in vivo studies using nude mice confirmed that BRMS1 inhibited blood vessel formation and the recruitment of CD31-positive cells in matrigel plugs. Taken together, BRMS1 expression was decreased in metastatic melanomas, which resulted in deficient suppression of angiogenesis and contributed to melanoma progression. BRMS1 may serve an important prognostic marker and therapeutic target for melanoma patients. Oncogene (2011) 30, 896-906; doi: 10.1038/onc.2010.470; published online 11 October 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据